<DOC>
	<DOCNO>NCT02646137</DOCNO>
	<brief_summary>Hepatocellular carcinoma third common cause cancer-related mortality . In recent year , transarterial chemoembolization , radio frequency ablation microwave ablation accept treatment modality patient surgically unresectable hepatocellular carcinoma .</brief_summary>
	<brief_title>Single Session Combined Locoregional Therapies Hepatocellular Carcinoma</brief_title>
	<detailed_description>To compare combination treatment radiofrequency microwave ablation follow transarterial chemoembolization perform single session .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Chlorotrianisene</mesh_term>
	<criteria>Child classification A B. serum albumin ≥ 3 gm/L . serum bilirubin &lt; 2.5 mg/dL . platelet count ≥70,000 mm3 . INR ≤ 1.6. serum creatinine &lt; 2 mg/dl . tumor size 4 cm confine one lobe liver . Patients portal vein thrombosis . A technically inaccessible hepatic artery . Metastatic HCC . More three lesion . lesion close proximity portal vein ( PV ) , inferior vena cava ( IVC ) gall bladder exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>